Post-Chicago Melanoma Meeting 2026
$60.00
On-Demand Course · Oncology-Hematology · 2026
The Post-Chicago Melanoma Meeting 2026 (EPCM) is a melanoma and skin cancer education program covering ASCO 2026 updates, immunotherapy, and precision oncology — designed for dermatologists and oncologists.
Post-Chicago Melanoma Meeting 2026 Covering ASCO Updates and Immunotherapy
The Post-Chicago Melanoma Meeting 2026 (EPCM) is the 16th edition of this European conference, organized under the Melanoma World Society and the European Association of Dermato Oncology (EADO). The program reviews the latest ASCO 2026 melanoma updates, non-melanoma skin cancer management, immune checkpoint inhibitor strategies, gene expression profiling, and personalized treatment sequencing for melanoma and skin cancer patients.
-
16thEdition
-
2026Meeting Year
-
15Learning Objectives
Inside this resource
ASCO 2026 Melanoma Updates
Sessions review the most important ASCO 2026 melanoma updates alongside emerging systemic therapies and clinical trial results.
Immunotherapy & Immune Checkpoint Inhibitors
Coverage addresses ICI strategies, timing of administration, immune-related toxicities, and rechallenge approaches for melanoma and skin cancer patients.
Non-Melanoma Skin Cancer & EADO Guidelines
Modules cover basal cell carcinoma, cutaneous squamous cell carcinoma, and the newest EADO 2026 clinical guidelines.
Precision Oncology & Rare Tumors
Sessions explore gene expression profiling, Merkel Cell Carcinoma, metastatic uveal melanoma, and ImmTACs/Tebentafusp-based therapies.
Who this serves
- Dermatologists and dermatopathologists — dermatologists and dermatopathologists are explicitly named as the intended audience for this program.
- Medical, surgical, and radiation oncologists — medical oncologists, surgical oncologists, and radiation oncologists are listed among who should watch.
- Oncology fellows and dermatology residents — oncology fellows and dermatology residents are named as target learners for the Post-Chicago Melanoma Meeting 2026.
- General and plastic surgeons involved in skin cancer care — general surgeons, plastic surgeons, and healthcare professionals involved in skin cancer care are listed as ideal participants.
Before you buy
What does the Post-Chicago Melanoma Meeting 2026 cover?
ASCO 2026 melanoma updates, non-melanoma skin cancer management, immunotherapy and immune checkpoint inhibitor strategies, gene expression profiling, and EADO 2026 clinical guidelines.
Who organizes this meeting?
The 16th European Post-Chicago Melanoma / Skin Cancer Meeting (EPCM) is organized under the Melanoma World Society (MWS) and the European Association of Dermato Oncology (EADO).
The chart
| Format | Complete conference educational package |
|---|---|
| Duration | 16th annual meeting, 2026 |
| Year | 2026 |
| Publisher | European Association of Dermato Oncology (EADO) / Melanoma World Society (MWS) |
| Department | Oncology-Hematology |
| Delivery | Instant download after checkout · lifetime re-access |
Verified original fileInstant downloadEncrypted checkout
Be the first to review “Post-Chicago Melanoma Meeting 2026”
Related products
Oncology-Hematology
Oncology-Hematology
Oncology-Hematology
Oncology-Hematology
Oncology-Hematology
Oncology-Hematology
Oncology-Hematology
Oncology-Hematology
Reviews
There are no reviews yet.